RS

Active Director Director DIN 11900868
DIN 11900868 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Riya Sah

Data last updated:

Riya Sah is a Director at Zyvion Biotech Private Limited (since 2026) and Director at Noventra Biotech Private Limited (since 2026).

DIN 11900868
Primary Designation Director
First Appointment 19 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zyvion Biotech Private Limited U21002BR2026PTC087778
Director04 Sep 20262026Active
Noventra Biotech Private Limited U47721BR2026PTC087459
Director19 Aug 20262026Active

Board colleagues of Riya Sah

Directorship timeline

Open interactive timeline →
Noventra Biotech Private Limited
Zyvion Biotech Private Limited
Premium access

Shareholding and investment profile for Riya Sah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Riya Sah

Riya Sah currently holds 2 directorships: Zyvion Biotech Private Limited (Director, since 04 Sep 2026); Noventra Biotech Private Limited (Director, since 19 Aug 2026).

Riya Sah was first appointed on 19 Aug 2026 as Director at Noventra Biotech Private Limited.

The current boards of Riya Sah's companies include Avinash Kumar (Zyvion Biotech Private Limited), Mihir Vyomeshchandra Baxi (Zyvion Biotech Private Limited), Manoj Kumar (Noventra Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available